Health Biotchnology Equity Positions Weight vs. Net Asset

SHPCX Fund  USD 13.63  0.05  0.37%   
Based on the key profitability measurements obtained from Health Biotchnology's financial statements, Health Biotchnology Portfolio may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Health Biotchnology's ability to earn profits and add value for shareholders.
For Health Biotchnology profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Health Biotchnology to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Health Biotchnology Portfolio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Health Biotchnology's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Health Biotchnology Portfolio over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
Please note, there is a significant difference between Health Biotchnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health Biotchnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health Biotchnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Health Biotchnology Net Asset vs. Equity Positions Weight Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Health Biotchnology's current stock value. Our valuation model uses many indicators to compare Health Biotchnology value to that of its competitors to determine the firm's financial worth.
Health Biotchnology Portfolio is rated top fund in equity positions weight among similar funds. It also is rated top fund in net asset among similar funds making up about  119,758  of Net Asset per Equity Positions Weight. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Health Biotchnology's earnings, one of the primary drivers of an investment's value.

HEALTH Net Asset vs. Equity Positions Weight

Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.

Health Biotchnology

Stock Percentage

 = 

% of Equities

in the fund

 = 
99.20 %
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

Health Biotchnology

Net Asset

 = 

Current Market Value

-

Current Liabilities

 = 
11.88 M
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.

HEALTH Net Asset Comparison

Health Biotchnology is currently under evaluation in net asset among similar funds.

Health Biotchnology Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Health Biotchnology, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Health Biotchnology will eventually generate negative long term returns. The profitability progress is the general direction of Health Biotchnology's change in net profit over the period of time. It can combine multiple indicators of Health Biotchnology, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund will normally invest at least 80 percent of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value . Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. The Adviser utilizes a top-down investment approach focused on long-term economic trends.

HEALTH Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Health Biotchnology. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Health Biotchnology position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Health Biotchnology's important profitability drivers and their relationship over time.

Use Health Biotchnology in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Health Biotchnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Health Biotchnology will appreciate offsetting losses from the drop in the long position's value.

Health Biotchnology Pair Trading

Health Biotchnology Portfolio Pair Trading Analysis

The ability to find closely correlated positions to Health Biotchnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Health Biotchnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Health Biotchnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Health Biotchnology Portfolio to buy it.
The correlation of Health Biotchnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Health Biotchnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Health Biotchnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Health Biotchnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Health Biotchnology position

In addition to having Health Biotchnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Energy Funds Thematic Idea Now

Energy Funds
Energy Funds Theme
Funds or Etfs investing in energy sector, natural resources, and ecology. The Energy Funds theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in HEALTH Mutual Fund

To fully project Health Biotchnology's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Health Biotchnology at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Health Biotchnology's income statement, its balance sheet, and the statement of cash flows.
Potential Health Biotchnology investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Health Biotchnology investors may work on each financial statement separately, they are all related. The changes in Health Biotchnology's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Health Biotchnology's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings